|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Serotonin (5-hydroxytryptamine [5-HT]) is a multifunctional amine with wide occurrence in both neural and non-neural tissues, including the lung. The diverse responses to 5-HT are elicited through activation of different 5-HT receptor subtypes. We report the expression and localization of 5-HT receptor 2c subtype (5-HT2c-R) in rat lungs using reverse transcriptase-polymerase chain reaction, nonisotopic in situ hybridization (NISH), and immunohistochemistry. At the messenger RNA (mRNA) level, signal corresponding to approximately 430 base pairs was detected in whole-lung tissue extracts as well as in cultures of isolated alveolar type II cells from fetal and adult rat lung. Using antisense RNA probe for 5-HT2c-R, NISH showed strong positive signal in type II cells. The expression of mRNA signal differed between fetal and adult rat type II cells, with weak, predominantly perinuclear localization in the former and strong cytoplasmic localization in the latter. Immunohistochemistry, using specific monoclonal antibody against 5-HT2c-R, showed perinuclear localization in fetal type II cells; whereas in adult type II cells 5-HT2c-R immunoreactivity was confined mostly to the plasma membrane, as demonstrated by laser confocal microscopy. Identification of 5-HT2c-R expression in alveolar type II cells suggests an important role for this amine in modulating the function of these cells. The differences in cell domain localization between fetal and adult type II cells could indicate developmental regulation of 5-HT2c-R expression in the lung.
| |
Introduction |
|---|
|
|
|---|
Serotonin (5-hydroxytryptamine, 5-HT) is an endogenous amine involved in diverse biologic processes within the central and peripheral nervous system and the cardiovascular and gastrointestinal and respiratory systems (1). In addition to its role as a neurotransmitter, 5-HT has been implicated as a potential mitogen (4, 5) and was shown to have effects on morphogenesis and neuronal development (6). This diversity of actions is made possible because of the existence of specific 5-HT cell-surface receptor subtypes and their coupling to distinct intracellular messenger systems or ion channels. A family of serotonin receptors (5-HT-R) and their respective genes have recently been identified (7) based on operational, structural, and transductional data. New classification of 5-HT-Rs, based on operational, structural, and transductional data, has divided 5-HT-Rs into seven classes and at least ten subtypes (8). In addition to structural differences, there are important differences in coupling to intracellular effectors. For example, receptors belonging to the 5-HT1-R family are thought to be negatively linked to adenylyl cyclase, whereas 5-HT2-Rs are coupled via phosphoinositol hydrolysis signal and 5HT3-R interacts directly with ion channels (8).
The distribution and localization of 5HT-Rs has been investigated extensively in the central nervous system, but there is much less data available on 5-HT-Rs in peripheral tissues. The lung is an important peripheral site for 5-HT action because this amine is known to produce contractile responses in both airway and vascular smooth muscle (9, 10). Further, inactivation of 5-HT in the pulmonary circulation by a carrier-active mechanism involving the endothelial cells is a well-established phenomenon (11).
The lung tissue is also known to be an important source of endogenous 5-HT, particularly in mast cells and pulmonary neuroendocrine cells (PNEC) (12, 13). The precise role of 5-HT synthesized and released from either the mast cells or PNEC is presently unknown, but may involve local effects such as bronchoconstriction, vasomotor tone, hypoxia signaling, and/or growth factor-like properties (14). In the present study we report expression and localization of the 5-HT receptor 2c subtype (5-HT2c-R) in rat alveolar type II cells at the messenger RNA (mRNA) level using reverse transcriptase-polymerase chain reaction (RT-PCR) and nonisotopic in situ hybridization (NISH), and at the protein level using immunohistochemistry. Because type II pneumocytes play a critical role in lung physiology, 5-HT and its receptor(s) may be involved in modulation of type II cell homeostatic activities. This appears to be a new and previously unsuspected role for this amine in pulmonary physiology and pathophysiology.
| |
Materials and Methods |
|---|
|
|
|---|
Lung tissues for NISH studies and for immunohistochemistry were obtained from adult Wistar rats. The tissues were fixed in 10% neutral buffered formalin, embedded in paraffin, and 5-µm sections were placed on sialinated slides. Fetal type II cells (Day 20 fetal gestation) were isolated as described by Caniggia and colleagues (15). The adult type II pneumocytes were isolated using a modification of the method of Dobbs (16). Briefly, adult rats were anesthetized and the lungs removed in toto. The type II cells were separated from the alveolar basement membrane by incubation with porcine pancreatic elastase followed by removal of macrophages by differential adherence on Fc-coated Petri dishes (Fisher Scientific, Ottawa, ON, Canada). Type II cells were identified in cytospin samples and in culture dishes by histochemical staining for alkaline phosphatase, a specific marker of type II cells (17).
Isolated cells were plated in Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum, 2 mM glutamine (GIBCO, Burlington, ON, Canada), 10 µg/ ml gentamycin, 100 µ/ml pencillin G, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B at an initial seeding density of 106 cells/cm2 in 24-well culture dishes (Falcon Multiwell; Becton-Dickinson Labware, Lincoln Park, NJ).
For NISH and imunohistochemical studies, isolated type II cells were grown on Lab-Tek tissue culture slides (GIBCO) and fixed in 4% paraformaldehyde for 1 min. Total RNAs from lung tissue and pellets of isolated type II cells were prepared by the guanidinium thiocyanate-phenol-chloroform extraction method of Chomczynski and Sacchi (18).
RT-PCR for 5-HT2c-R
The 5-HT2c-R complementary DNA (cDNA) fragment was synthesized using RT-PCR. The first-strand cDNA (19) was prepared from total RNA extracted from rat lung, brain, and type II cell cultures. According to the published information on 5-HT2c-R (previously referred to as 1c) (20), we selected the regions 899 to 916 base pairs (bp) (on the first strand) and 1,327 to 1,310 bp (on the complementary strand), then synthesized two oligomers as the primers: 5' GCACCATGCAAGCTATCA 3' and 5' AGTTCTCCACCTGCATCT 3'.
For PCR reaction, the thermal cycle was 94°C for 30 s, 54°C for 60 s, and 72°C for 30 s. It was amplified for 35 cycles using first-strand cDNA as template, according to the protocol for DNA amplification from Perkin-Elmer (Norwalk, CT). A 430-bp rat 5-HT2c-R cDNA fragment (from 899 to 1,327 bp) was amplified.
NISH and Immunohistochemistry Procedures
To generate an antisense RNA probe for 5-HT2c-R, the 430-bp fragment was digested with restriction enzyme SstI and HindIII. Subsequently the SstI/HindIII 5-HT2c-R fragment (186 bp, i.e., 1,050 to 1,235 bp) was subcloned into SP72 vector (at SstI and HindIII sites). We sequenced this 186-bp insert to confirm that it corresponded to 5-HT2c-R cDNA fragment (sequencing data not shown). The vectors with inserts were linearized by restriction enzyme HindIII, and T7 RNA polymerase was used to synthesize nonradiolabeled RNA antisense probes (21).
The protocol for NISH was similar to that described previously (21). The immunohistochemistry for surfactant protein (SP) A used methods and procedures as described by Phelps and Harding (22). For correlation of mRNA hybridization signal with respective protein product, the sections were first immunostained with anti-SP-A rabbit polyclonal antibody (1:50 dilution) and reaction was visualized by the immunoperoxidase method according to Sternberger (23). Subsequently, NISH was carried out with digoxigenin-labled 5-HT2c-R cRNA probe (19). Purified mouse monoclonal antibody (PharMingen, San Diego, CA) (1:200) was used for immunohistochemistry to localize 5-HT2c-R in fetal and adult type II cell cultures. The incubation with primary antibody was followed by secondary goat antimouse immunoglobulin (Ig)G with peroxidase (Bio-Rad, Hercules, CA) and an immunopure metal- enhanced diaminobenzidine (DAB) substrate kit (Pierce, Rockford, IL). To test immunostaining specificity, the rat-brain synaptic plasma membrane preparation was used to block the specific 5-HT2c-R antibody according to instructions from the manufacturer (24). The 5-HT2c-R antibody was preincubated with rat-brain synaptic membranes at 37°C for 1 h, then applied to preparation of type II cells followed by peroxidase-conjugated goat antimouse IgG with peroxidase and DAB color developing. For immunofluorescence studies we used antimouse IgM conjugated with fluorescein isothiocyanate (FITC) (PharMingen) as a secondary antibody. In addition to routine immunofluorescence microscopy, we used laser confocal microscopy (Leitz TCS 4D confocal microscope with argon krypton laser excitation at 488 nm for FITC and a pinhole of 40 µm). Signals were analyzed using Scanware (Leica, Heerbrugg, Switzerland.).
| |
Results |
|---|
|
|
|---|
We used RT-PCR to detect gene expression of 5-HT2c-R in extracts of cultures of isolated type II cells from fetal and adult animals as well as whole adult rat lung. In all these samples mRNA signal corresponding to approximately 430 bp was detected, with the same signal present in whole rat brain extract used as a positive control (Figure 1).
|
To localize 5-HT2c-R mRNA expression at the cellular level we used antisense RNA probe and NISH protocol. In adult type II cell cultures there was a strong positive 5-HT2c-R mRNA signal localized within the cytoplasm, whereas the nuclei showed no reactivity (Figure 2A). The specificity of NISH reaction was confirmed using the same type of sample but hybridized with a sense probe, resulting in negative signal in type II cell preparations (Figure 2C). In cultures of fetal type II cells, the positive signal was localized mostly in the perinuclear area with a weak staining of the adjacent cytoplasm (Figure 2B). To identify alveolar type II cells in sections of rat lung, we first used immunocytochemistry with an anti-SP-A antibody. Alveolar type II cells showed positive cytoplasmic immunostaining for SP-A (Figure 3A). NISH performed on the same sections using antisense 5-HT2c-R probe showed positive signal colocalized in type II cells with SP-A immunoreactivity (Figure 3B).
|
To localize 5-HT2c-R at the protein level, we used specific monoclonal antibody against 5-HT2c-R on type II cell preparations. In samples of adult rat type II cells, positive immunoreactivity for 5-HT2c-R was localized mostly in the plasma membrane (Figure 4A). The specificity of immunoreactivity was confirmed by a blocking experiment in which immunoreactivity was abolished by preincubation of 5-HT2c-R antibody with rat-brain synaptic membrane preparation (Figure 4B).
The immunolocalization of 5-HT2c-R in rat fetal type II cells differed from that of type II cells from adult rats in that the positive signal was localized mostly in the perinuclear cytoplasm (Figure 5A). This reaction was abolished in a blocking experiment (Figure 5B) as shown for adult type II cell preparation.
The cellular localization and topography of 5-HT2c-R in type II cells was further examined using immunofluorescence and laser confocal microscopy. The samples of adult rat type II cells showed strong immunofluorescence signal for 5-HT2c-R on the plasma membrane with minimal nuclear immunoreactivity (Figure 6A). In contrast, fetal rat type II cells showed strong perinuclear immunoreactivity with minimal membrane immunostaining (Figure 6B).
| |
Discussion |
|---|
|
|
|---|
The main finding of this study is the identification and localization of 5-HT2c-R in alveolar type II cells of both fetal and adult rat lungs. Although 5-HT2c-R shares many similarities with other 5-HT receptors, especially those in group 2 (7, 8), we used antisense RNA probe synthesized from 1,050 to 1,235 bp, close to the 3' end of the coding region. According to Julius and coworkers (7, 20), this region is relatively unique and therefore unlikely to cross-hybridize with other 5-HT2-R subtypes. At the mRNA level, gene expression for 5-HT2c-R was identified by RT-PCR in extracts of isolated type II cell cultures as well as extracts of whole lung. Using NISH, strong signal for 5-HT2c-R mRNA was localized in the cytoplasm of adult rat type II cells; whereas in fetal type II cells, the signal was weaker and was localized mostly in the perinuclear areas. At the receptor protein level, the pattern of 5-HT2c-R localization was investigated by immunohistochemistry. In adult rat type II cells, 5-HT2c-R immunoreactivity was localized primarily in the plasma membrane; whereas in fetal type II cells, positive immunoreactivity was found in the perinuclear region. There are several possible explanations for these findings. The differences in the localization of 5-HT2c-R between fetal and adult type II cells could reflect developmental regulation. It should be noted, however, that in fetal rat brain, 5-HT-Rs appear fully functional and play a role in neuronal development (25). The other possibility could involve intracellular trafficking of receptor protein with translocation of receptors between the cell surface and endosomes (26). This situation may be analogous to that reported for muscarinic acetylcholine receptor (ACh-R), where agonist-induced intracellular receptor trafficking appears to be cell type- and receptor subtype- dependent (27). Significant agonist-induced internalization of receptor was observed in fibroblast (HeLa) and epithelial (HT29) cell lines, both of which express the m3 subtype of ACh-R (26). Although it is presently not known whether the differences in 5-HT2c-R localization in type II cells are agonist-induced, it is well established that the distribution and frequency of 5-HT immunoreactive PNEC as well as 5-HT concentration in lung tissues show striking changes during development (28, 29). In most species, PNEC are more numerous in fetal/neonatal lungs than in those of adults (28). In the rat lung, however, the principal source of 5-HT appears to be mast cells, with significantly higher concentrations of 5-HT reported in the adult as compared with the neonate (29). Further studies are required to determine the precise mechanism of 5-HT2c-R trafficking and its expression in alveolar type II cells during lung development.
The alveolar type II cells are involved in a variety of
important functions in the lung, including surfactant synthesis, ion transport, and alveolar repair following injury
(30). Whether 5-HT and its receptor are involved in any of
these processes is currently speculative. Earlier studies
suggested that 5-HT may inhibit amiloride-sensitive Na+
absorption in respiratory epithelium (31). These authors
suggested that because 5-HT is an indoleamine structurally similar to amiloride, its role may involve local regulations of Na+ absorption, complementing the action of mineralocorticoids (31). The possible involvement of 5-HT2c-R
in ion transport is strengthened by the observation that
this receptor is highly expressed at the apical membrane of
chorioid plexus epithelial cells, known to be involved in
the production and secretion of cerebrospinal fluid (22,
32). Further, mRNA derived from brain expressed in Xenopus oocyte model (normally not responsive to 5-HT)
shows increased Cl
conductances after application of
5-HT (33, 34). In the same model, 5-HT2c-R expressed
from cloned DNA was shown to mediate the closing of coexpressed rat-brain K+ channels in a Ca2+-independent
manner (34).
The effects of 5-HT as a mitogen and/or growth factor have recently been documented as a part of neuromodulator substances acting via G protein-coupled receptor signaling pathway (4, 5, 7). Specifically, 5-HT has been shown to increase DNA synthesis in rat pulmonary vascular smooth-muscle cells in culture (35). These effects, however, are mediated via 5-HT2a-R subtype. Of interest are studies with NIH 3T3 cells, where introduction of functional 2HT-2a-R and 2-HT2c-R results in generation of transformed foci at high frequency (36). The long-term maintenance of the transformed state requires continued activation of these 5-HT receptors, indicating that they may represent conditional proto-oncogenes (7). Although the direct effects of 5-HT on alveolar type II cell proliferation have not yet been investigated, we speculate that its actions in the alveolus could involve regulation of epithelial cell turnover as well as repair after injury.
Finally, our findings are consistent with a notion that the expression of different 5-HT-R subtypes in lung cells underlies the diversity of pulmonary responses induced by 5-HT released locally. Because lung parenchyma is a source of a variety of regulatory peptides, amine, and other bioactive substances (14), the direct effects as well as their interactions are likely to be multiple and complex. The full characterization of 5-HT-Rs in lung cells and their role in pulmonary function in normal and disease states await future investigations.
| |
Footnotes |
|---|
Abbreviations: base pairs, bp; serotonin, 5-HT; serotonin receptor, 5-HT-R; 5-HT receptor 2c subtype, 5-HT2c-R; immunoglobulin, Ig; messenger RNA, mRNA; nonisotopic in situ hybridization, NISH; pulmonary neuroendocrine cells, PNEC; reverse transcriptase-polymerase chain reaction, RT-PCR; surfactant protein, SP.
(Received in original form September 4, 1998 and in revised form October 30, 1998).
Acknowledgments: The authors thank Dr. J. Edelson for providing cultures of adult rat type II cells used in this study, and V. Wong for technical assistance with immunohistochemical methods. This work was supported by a grant from the Medical Research Council of Canada (MRC Group on Lung Development).
| |
References |
|---|
|
|
|---|
1. Fozard, Y. R., editor. 1989. The Principal Actions of 5-HT. Oxford University Press, Oxford, UK.
2. Whitaker-Azmitia, P. M., and S. J. Peroutka, editors. 1990. The Neuropharmacology of Serotonin, Vol. 600. The New York Academy of Sciences, New York.
3.
Hindle, A. T..
1994.
Recent developments in the physiology and pharmacology of 5-hydroxytryptamine.
Br. J. Anaesth.
73:
395-407
4. Seuwen, K., I. Magnaldo, and J. Pouyssegur. 1988. Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a G-protein. Nature 335: 254-256 [Medline].
5. Seuwen, K., and J. Pouyssegur. 1990. Serotonin as a growth factor. Biochem. Pharmacol. 39: 985-990 [Medline].
6. Lauder, J. M. 1990. Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. In The Neuropharmacology of Serotonin, Vol. 600. P. M. Whitaker-Azmitia and S. J. Peroutka, editors. The New York Academy of Sciences, New York. 297-314.
7. Julius, D.. 1991. Molecular biology of serotonin receptors. Annu. Rev. Neurosci. 14: 335-360 [Medline].
8. Humphrey, P. P. A., P. Hartig, and D. Hoyer. 1993. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14: 233-236 [Medline].
9. Selig, W. M., M. A. Bloomquist, M. L. Cohen, and J. H. Fleisch. 1988. Serotonin-induced responses in perfused guinea pig lung: evidence for 5HT2 receptor-mediated pulmonary vascular and airway smooth muscle constriction. Pulm. Pharmacol. 1: 93-99 [Medline].
10.
Martin, T. R.,
M. L. Cohen, and
J. M. Drazen.
1994.
Serotonin-induced pulmonary responses are mediated by the 5-HT2 receptor in the mouse.
J.
Pharmacol. Exp. Ther.
268:
104-109
11. Alabaster, V. A. 1977. Inactivation of endogenous amines in the lungs. In Metabolic Functions of the Lung: Lung Biology in Health and Disease. Y. S. Bakhle and J. R. Vane, editors. Marcel-Dekker, New York. 3-31.
12. Erspaner, V. 1966. Occurrence of indolealkyl amines in nature. In Handbuch der Experimentellen Pharmakologie, Vol. 19. O. Eichler and A. Farah, editors. Springer, Berlin. 132-181.
13. Lauweryns, J. M., M. Cokelaere, and P. Theunynck. 1972. Serotonin-producing neuroepithelial bodies in rabbit respiratory mucosa. Science 180: 410-413 .
14. Cutz, E., J. E. Gillan, and D. G. Perrin. 1995. Pulmonary neuroendocrine cell system: an overview of cell biology and pathology with emphasis on pediatric lung disease. In Pulmonary Disease, Vol. 18. F. B. Askin, C. Langston, H. S. Rosenberg, and J. Bernstein, editors. Karger, Basel. 32-70.
15. Caniggia, I., I. Tsen, R. N. N. Han, B. T. Smith, K. Tanswell, and M. Post. 1991. Spatial and temporal differences in fibroblast behaviour in fetal rat lung. Am. J. Physiol. 261 (Lung Cell. Mol. Physiol.):L424-L433.
16. Dobbs, L. G. 1990. Isolation and culture of alveolar type II cells. Am. J. Physiol. 258 (Lung Cell. Mol. Physiol.):L134-L147.
17. Edelson, J. D., J. M. Shannon, and R. J. Mason. 1988. Alkaline phosphatase: a marker of alveolar type II cell differentiation. Am. Rev. Respir. Dis. 138: 1268-1275 [Medline].
18. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159 [Medline].
19.
Sarkar, G., and
S. S. Sommer.
1989.
Access to messenger RNA sequence or
its protein product is not limited by tissue or species specificity.
Science
244:
331-334
20.
Julius, D.,
A. B. McDermott,
R. Axle, and
T. M. Jessell.
1988.
Molecular
characterization of functional cDNA encoding the serotonin 1c receptor.
Science
241:
558-565
21. Wang, D., and E. Cutz. 1994. Simultaneous detection of messenger ribonucleic acids for bombesin/gastrin-releasing peptide and its receptor in rat brain by nonradiolabeled double in situ hybridization. Lab. Invest. 70: 775-780 [Medline].
22. Phelps, D. S., and H. P. Harding. 1987. Immunohistochemical localization of a low molecular weight surfactant-associated protein in human lung. J. Histochem. Cytochem. 35: 1339-1342 [Abstract].
23. Sternberger, L. A. 1986. Immunocytochemistry, 3rd ed. John Wiley & Sons, New York.
24. Rogers, S. W., T. E. Hughes, M. Hollman, G. P. Gasic, E. S. Deneris, and S. F. Heinemann. 1991. The characterization and localization of the glutamate receptor subunit GluR1 in the rat brain. J. Neurosci. 11: 2713-2724 [Abstract].
25. Whitaker-Azmitia, P. M., J. M. Lauder, A. Shemmer, and E. C. Azmitia. 1987. Postnatal changes in serotonin receptors following prenatal alterations in serotonin levels: further evidence for functional fetal serotonin receptors. Dev. Brain Res. 33: 285-289 .
26. Lauffenburger, D. A., and J. J. Lindermann. 1993. Receptors: Models for Binding, Trafficking and Signaling. Oxford University Press, Oxford, UK.
27. Koenig, J. A., and J. M. Edwardson. 1996. Intracellular trafficking of the muscarinic acetylcholine receptor: importance of subtype and cell type. Mol. Pharmacol. 49: 351-359 [Abstract].
28. Cho, T., W. Chan, and E. Cutz. 1989. Distribution and frequency of neuro-epithelial bodies in post-natal rabbit lung: quantitative study with monoclonal antibody against serotonin. Cell Tissue Res. 255: 353-362 [Medline].
29. Freitag, A., I. Wessler, and K. Racke. 1995. Characterization of 5-hydroxytryptamine release from isolated rabbit and rat trachea: the role of neuroendocrine epithelial cells and mast cells. Naunyn Schmiedeberg's Arch. Pharmacol. 353: 55-63 [Medline].
30. Voelker, D. R., and R. J. Mason. 1989. Alveolar type II epithelial cells. In Lung Cell Biology. D. Massaro, editor. Marcel Dekker, New York. 487-538.
31. Legris, G. J., P. C. Will, and U. Hopfer. 1981. Effects of serotonin on ion transport in intestinal and respiratory epithelium. In Hormonal Regulation of Epithelial Transport of Ions and Water. W. N. Scott and D. P. P. Goodman, editors. The New York Academy of Sciences, New York. 372:345-346.
32.
Conn, J. P.,
E. Sanders-Bush,
B. J. Hoffman, and
P. R. Hartig.
1986.
A
unique serotonin receptor in chorioid plexus is linked to phosphatidylinositol turnover.
Proc. Natl. Acad. Sci. USA
83:
4086-4088
33. Gundersene, B., F. R. S. Miledi, and I. Parker. 1983. Serotonin receptors induced by exogenous messenger RNA in Xenopus oocytes. Proc. R. Soc. Lond. B. Biol. Sci. 219: 103-109 [Medline].
34.
Panicker, M. M.,
I. Parker, and
R. Miledi.
1991.
Receptors of the serotonin
1C subtype expressed from cloned DNA mediate the closing of K+ membrane channels encoded by brain mRNA.
Proc. Natl. Acad. Sci. USA
88:
1560-1565
35. Pitt, B. R., W. Wing, A. R. Steve, R. D. Bleakly, I. Reynolds, and P. Davies. 1994. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol.):L178-L186.
36.
Julius, D.,
T. J. Livelli,
T. M. Jessell, and
R. Axel.
1989.
Extopic expression
of the serotonin 1c receptor and the triggering of malignant transformation.
Science
244:
1057-1062
This article has been cited by other articles:
![]() |
J. Pan, I. Copland, M. Post, H. Yeger, and E. Cutz Mechanical stretch-induced serotonin release from pulmonary neuroendocrine cells: implications for lung development Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L185 - L193. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. W. Fu, D. Wang, J. Pan, S. M. Farragher, V. Wong, and E. Cutz Neuroepithelial bodies in mammalian lung express functional serotonin type 3 receptor Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L931 - L940. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |